The effect of dental gel with IL-1β antagonist on indicators of nitrosative stress and antioxidant system in rats with experimental chronic generalized periodontitis

Authors

DOI:

https://doi.org/10.14739/mmt.2024.3.303351

Keywords:

chronic periodontitis, IL-1β receptor antagonist, dental gel, nitrosative stress

Abstract

The aim of the study was to evaluate the action of dental gel with IL-1β receptor antagonist on the indicators of nitrosative stress and antioxidant system in rats with experimental chronic generalized periodontitis.

Materials and methods. Experimental chronic generalized periodontitis (CGP) was modeled using a calcium-deficient peroxide diet with reduced masticatory function in Wistar rats weighing 190–220 g for 8 weeks. The studied pharmacological agents were administered within 30 days after the development of CGP: 1 % dental gel with IL-1β receptor antagonist (1 mg/kg, locally using a dispenser); and antioxidant Mexidol (250 mg/kg, intragastrically). To assess the condition of periodontal tissues, the levels of nitrotyrosine, iNOS, Cu/ZnSOD, and glutathione peroxidase-4 were determined by immunoenzymatic quantitative analysis; levels of stable metabolites of NO, reduced and oxidized glutathione were determined using biochemical methods.

Results. Course administration of dental gel with IL-1β antagonist in a therapeutic regimen to rats with CGP resulted in a decrease in the depth of periodontal pockets, almost complete elimination of bleeding and swelling of the gums, as well as to a decrease in iNOS expression by 37.8 % (p < 0.05), nitrotyrosine concentration – by 55.2 %, and NO metabolites – by 30 % (p < 0.05) in the blood of animals. Dental gel with IL-1β antagonist application resulted in an increase in concentration of reduced glutathione by 63 % (p < 0.05), glutathione peroxidase-4 expression – by 60.4 % (p < 0.05), and Cu/ZnSOD – by 31.2 % (p < 0.05) in the blood of animals with CGP. Mexidol, when administered to rats with CGP, affected only two studied indices – the level of nitrotyrosine and reduced glutathione (p < 0.05). However, it was inferior to the gel with the IL-1β receptor antagonist in terms of the degree of influence on these parameters (р < 0.05).

Conclusions. The obtained results provide experimental justification for further study of IL-1β antagonist as a promising agent for the treatment of CGP.

Author Biographies

O. O. Dmytriieva, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

Postgraduate student of the Department of Propaedeutic and Surgical Dentistry

I. F. Bielenichev, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

PhD, DSc, Professor, Head of the Department of Pharmacology and Medical Formulation with Course of Normal Physiology

I. B. Samura, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, Associate Professor of the Department of Pharmacology and Medical Formulation with Course of Normal Physiology

V. I. Salnykov, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, Assistant of the Department of Propaedeutic and Surgical Dentistry

D. V. Robota, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, Assistant of the Clinical Laboratory Diagnostics

References

  1. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72-80.
  2. Jepsen S, Blanco J, Buchalla W, Carvalho JC, Dietrich T, Dörfer C. et al. Prevention and control of dental caries and periodontal diseases at individual and population level: consensus report of group 3 of joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol. 2017;44 Suppl 18:S85-S93. doi: https://doi.org/10.1111/jcpe.12687
  3. Yazdanian M, Armoon B, Noroozi A, Noroozi A, Mohammadi R, Bayat Amir-Hosein, et al. Dental caries and periodontal disease among people who use drugs: a systematic review and meta-analysis. BMC Oral Health. 2020;20(1):44. doi: https://doi.org/10.1186/s12903-020-1010-3
  4. Reddahi S, Bouziane A, Rida S, Tligui H, Ennibi O. Salivary Biomarkers in Periodontitis Patients: A Pilot Study. Int J Dent. 2022;2022:3664516. doi: https://doi.org/10.1155/2022/3664516
  5. Qasim SS, Al-Otaibi D, Al-Jasser R, Gul SS, Zafar MS. An evidence-based update on the molecular mechanisms underlying periodontal diseases. Int J Mol Sci. 2020;21(11):3829. doi: https://doi.org/10.3390/ijms21113829
  6. Bhuyan R, Bhuyan SK, Mohanty JN, Das S, Juliana N, Juliana IF. Periodontitis and its inflammatory changes linked to various systemic diseases: a review of its underlying mechanisms. Biomedicines. 2022;10(10):2659. doi: https://doi.org/10.3390/biomedicines10102659
  7. Sarhan MH, Farghaly A, Abd El-Aal NF, Mohammed Farag S, Ahmed Ali A, Farag TI. Egyptian propolis and selenium nanoparticles against murine trichinosis: a novel therapeutic insight. J Helminthol. 2022;96:e50. doi: https://doi.org/10.1017/S0022149X22000359
  8. Lu X, Mestres G, Singh VP, Effati P, Poon JF, Engman L, et al. Selenium- and Tellurium-Based Antioxidants for Modulating Inflammation and Effects on Osteoblastic Activity. Antioxidants (Basel). 2017;6(1):13. doi: https://doi.org/10.3390/antiox6010013
  9. Parkhomenko D, Belenichev IF, Kuchkovskyi OM, Ryzhenko V. Characteristics of HIF-1Α and HSP70 MRNA Expression, Level, and Inter-leukins in Experimental Chronic Generalized Periodontitis. Microrna. 2024;13(2):132-9. doi: https://doi.org/10.2174/0122115366264794240327073739
  10. Vo TT, Chu PM, Tuan VP, Te JS, Lee IT. The Promising Role of Antioxidant Phytochemicals in the Prevention and Treatment of Periodontal Disease via the Inhibition of Oxidative Stress Pathways: Updated Insights. Antioxidants (Basel). 2020;9(12):1211. doi: https://doi.org/10.3390/antiox9121211
  11. Sparrow TV, Dodington DW, Yumol JL, Fritz PC, Ward WE. Higher intakes of flavonoids are associated with lower salivary IL-1β and maintenance of periodontal health 3-4 years after scaling and root planning. J Clin Periodontol. 2020;47(4):461-9. doi: https://doi.org/10.1111/jcpe.13263
  12. Gallorini M, Rapino M, Schweikl H, Cataldi A, Amoroso R, Maccallini C. Selective inhibitors of the inducible nitric oxide synthase as modulators of cell responses in LPS-stimulated human monocytes. Molecules. 2021;26(15):4419. doi: https://doi.org/10.3390/molecules26154419
  13. Kitaura H, Marahleh A, Ohori F, Noguchi T, Shen WR, Qi J, et al. Osteocyte-related cytokines regulate osteoclast formation and bone resorption. Int J Mol Sci. 2020;21(14):5169. doi: https://doi.org/10.3390/ijms21145169
  14. Martemucci G, Costagliola C, Mariano M, D’andrea L, Napolitano P, D’Alessandro AG. Free radical properties, source and targets, antioxidant consumption and health. Oxygen. 2022;2(2):48-78. doi: https://doi.org/10.3390/oxygen2020006
  15. Cheng R, Wu Z, Li M, Shao M, Hu T. Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review. Int J Oral Sci. 2020;12(1):2. doi: https://doi.org/10.1038/s41368-019-0068-8
  16. Mao R, Zong N, Hu Y, Chen Y, Xu Y. Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke. Neurosci Bull. 2022;38(10):1229-47. doi: https://doi.org/10.1007/s12264-022-00859-0
  17. Lyu Q, Wawrzyniuk M, Rutten VP, van Eden W, Sijts AJ, Broere F. Hsp70 and NF-kB Mediated Control of Innate Inflammatory Responses in a Canine Macrophage Cell Line. Int J Mol Sci. 2020;21(18):6464. doi: https://doi.org/10.3390/ijms21186464
  18. Dmytriieva ОО, Belenichev IF, Burlaka BS. Optimisation of the composition of safe dental gel with IL-1β antagonist for the treatment of inflammatory periodontal diseases. Zaporozhye medical journal. 2024;26(2):134-43. doi: https://doi.org/10.14739/2310-1210.2024.2.292521
  19. Gorokhivsky VN, Schneider SA, Tkachenko EK. [Development of an experimental model of periodontitis]. Innovatsii v stomatolohii. 2018;0(17):56-60. Russian.
  20. McPherson RA, Pincus MR. Henry’s clinical diagnosis and management by laboratory methods. 24th ed. Philadelphia, PA: Elsevier - Health Sciences Division; 2021.
  21. Rojas C, García MP, Polanco AF, González-Osuna L, Sierra-Cristancho A, Melgar-Rodríguez S, et al. Humanized Mouse Models for the Study of Periodontitis: An Opportunity to Elucidate Unresolved Aspects of Its Immunopathogenesis and Analyze New Immunotherapeutic Strategies. Front Immunol. 2021;12:663328. doi: https://doi.org/10.3389/fimmu.2021.663328
  22. Tsioumpekou M, Krijgsman D, Leusen JH, Olofsen PA. The role of cytokines in neutrophil development, tissue homing, function and plasticity in health and disease. Cells. 2023;12(15):1981. doi: https://doi.org/10.3390/cells12151981
  23. Radzki D, Negri A, Kusiak A, Obuchowski M. Matrix Metalloproteinases in the periodontium—vital in tissue turnover and unfortunate in periodontitis. Int J Mol Sci. 2024;25(5):2763. doi: https://doi.org/10.3390/ijms25052763
  24. Behm C, Nemec M, Blufstein A, Schubert M, Rausch-Fan X, Andrukhov O, et al. Interleukin-1β induced matrix metalloproteinase expression in human periodontal ligament-derived mesenchymal stromal cells under in vitro simulated static orthodontic Forces. Int J Mol Sci. 2021;22(3):1027. doi: https://doi.org/10.3390/ijms22031027
  25. Ma Y, Song X, Ma T, Li Y, Bai H, Zhang Z, et al. Aminoguanidine inhibits IL-1β-induced protein expression of iNOS and COX-2 by blocking the NF-κB signaling pathway in rat articular chondrocytes. Exp Ther Med. 2020;20(3):2623-30. doi: https://doi.org/10.3892/etm.2020.902
  26. Andrés CM, Pérez de la Lastra JM, Andrés Juan C, Plou FJ, Pérez-Lebeña E. Superoxide anion chemistry-its role at the core of the innate immunity. Int J Mol Sci. 2023;24(3):1841. doi: https://doi.org/10.3390/ijms24031841
  27. Kanzaki H, Wada S, Narimiya T, Yamaguchi Y, Katsumata Y, Itohiya K, et al. Pathways that regulate ROS scavenging enzymes, and their role in defense against tissue destruction in periodontitis. Front Physiol. 2017;8:351. doi: https://doi.org/10.3389/fphys.2017.00351
  28. Trivedi S, Lal N. Antioxidant enzymes in periodontitis. J Oral Biol Craniofac Res. 2017;7(1):54-7. doi: https://doi.org/10.1016/j.jobcr.2016.08.001
  29. Wang F, Yuan Q, Chen F, Pang J, Pan C, Xu F, et al. Fundamental mechanisms of the cell death caused by nitrosative stress. Front Cell Dev Biol. 2021;9:742483. doi: https://doi.org/10.3389/fcell.2021.742483
  30. Wasti J, Wasti A, Singh R. Efficacy of antioxidants therapy on progression of periodontal disease - A randomized control trial. Indian J Dent Res. 2021;32(2):187-91. doi: https://doi.org/10.4103/ijdr.IJDR_227_20
  31. Zhang R, Lei J, Chen L, Wang Y, Yang G, Yin Z. et al. γ-Glutamylcysteine exerts neuroprotection effects against cerebral ischemia/reperfusion injury through inhibiting lipid peroxidation and ferroptosis. Antioxidants 2022;11:1653. doi: https://doi.org/10.3390/antiox11091653
  32. Weaver K, Skouta R. The selenoprotein glutathione peroxidase 4: from molecular mechanisms to novel therapeutic opportunities. Biomedicines. 2022;10(4):891. doi: https://doi.org/10.3390/biomedicines10040891
  33. Kwon DH, Lee H, Park C, Hong SH, Hong SH, Kim GY, et al. Glutathione induced immune-stimulatory activity by promoting M1-like macrophages polarization via potential ROS scavenging capacity. Antioxidants (Basel). 2019;8(9):413. doi: https://doi.org/10.3390/antiox8090413
  34. Di Stasi LC. Coumarin Derivatives in Inflammatory Bowel Disease. Molecules. 2021;26(2):422. doi: https://doi.org/10.3390/molecules26020422
  35. Luís JP, Simões CJ, Brito RM. The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. Int J Mol Sci. 2022;23(3):1731. doi: https://doi.org/10.3390/ijms23031731

Downloads

Additional Files

Published

2024-09-30

How to Cite

Dmytriieva, O. O., Bielenichev, I. F., Samura, I. B., Salnykov, V. I., & Robota, D. V. (2024). The effect of dental gel with IL-1β antagonist on indicators of nitrosative stress and antioxidant system in rats with experimental chronic generalized periodontitis. Modern Medical Technology, 16(3), 214–219. https://doi.org/10.14739/mmt.2024.3.303351

Issue

Vol. 16 No. 3 (2024)

Section

Original research

License

The work is provided under the terms of the Public Offer and of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows an unlimited number of persons to reproduce and share the Licensed Material in all media and formats. Any use of the Licensed Material shall contain an identification of its Creator(s) and must be for non-commercial purposes only.